DMAAU vs PDYN
Comparison between Drugs Made In America Acquisition Corp - Units (1 Ord Shs & 1 Rts) (DMAAU, Company) and Palladyne AI Corp (PDYN, Company).
DMAAU is from the Financial Services sector, while PDYN is from the Technology sector.
DMAAU vs PDYN - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
DMAAU vs PDYN - Historical Returns
Returns include dividend reinvestment.
DMAAU vs PDYN - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | DMAAU | PDYN |
|---|---|---|
| 2026 | +4.77% | +9.53% |
| 2025 | +4.90% | -63.78% |
| 2024 | N/A | +1721.83% |
| 2023 | N/A | -80.92% |
| 2022 | N/A | -94.28% |
| 2021 | N/A | +9.67% |
DMAAU vs PDYN Drawdown Comparison
The maximum drawdown for DMAAU was -6.27%, occurring on Jun 17, 2026. This drawdown has not yet recovered.
The maximum drawdown for PDYN was -99.23%, occurring on Feb 6, 2024. This drawdown has not yet recovered.
The current DMAAU drawdown is -2.92%. The current PDYN drawdown is -91.37%.
| Rank | DMAAU | PDYN |
|---|---|---|
| #1 | -6.27% Jun 8, 2026 - Jun 17, 2026 | -99.23% Dec 30, 2021 - Feb 6, 2024 |
| #2 | -3.26% Jun 2, 2026 - Jun 8, 2026 | -33.19% Sep 27, 2021 - Dec 21, 2021 |
| #3 | -2.17% Aug 5, 2025 - May 21, 2026 | -0.81% Dec 27, 2021 - Dec 30, 2021 |
| #4 | -2.10% Jun 2, 2025 - Jul 29, 2025 | -0.73% Dec 21, 2021 - Dec 27, 2021 |
| #5 | -1.93% May 21, 2026 - Jun 2, 2026 | N/A |
| #6 | -0.98% Feb 28, 2025 - Apr 29, 2025 | N/A |
| #7 | -0.29% Apr 29, 2025 - May 6, 2025 | N/A |
| #8 | -0.20% Feb 14, 2025 - Feb 21, 2025 | N/A |
| #9 | -0.10% May 13, 2025 - May 15, 2025 | N/A |
| #10 | -0.05% Feb 24, 2025 - Feb 28, 2025 | N/A |
| #11 | -0.05% Jan 30, 2025 - Feb 4, 2025 | N/A |
| #12 | -0.05% Feb 4, 2025 - Feb 7, 2025 | N/A |
| #13 | -0.04% Feb 11, 2025 - Feb 13, 2025 | N/A |
| #14 | -0.01% May 6, 2025 - May 13, 2025 | N/A |
Correlation
Correlation between DMAAU and PDYN is -0.23 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks